发明名称 Compositions comprising biomembrane sealing agent for treatment of neuronal injury, and methods of use
摘要 The invention provides compositions, kits, and methods for treatment of neuronal injury. In one embodiment, the composition comprises a biomembrane sealing agent, such as PEG, and a bioactive agent, such as a magnesium compound. The biomembrane sealing agent and/or the bioactive agent an intravenous administration, an intramuscular administration, an intrathecal administration, a subcutaneous administration, an epidural administration, a parenteral administration, a direct application onto or adjacent to a site of the pathological condition, and any combinations thereof. Alternatively, the biomembrane sealing agent and/or the bioactive agent may be delivered from a pump or an implant.
申请公布号 US8945623(B2) 申请公布日期 2015.02.03
申请号 US200611418152 申请日期 2006.05.03
申请人 Warsaw Orthopedic, Inc. 发明人 Roy Josee;McKay William F.;Marx Jeffrey C.
分类号 A61K38/20;A61K38/18;A61K38/11;A61K38/05;A61K31/65;A61K31/56;A61K9/14;A61K9/00;A61K33/06;A61K47/10 主分类号 A61K38/20
代理机构 Sorell, Lenna & Schmidt LLP 代理人 Schmidt William D.;Sorell, Lenna & Schmidt LLP
主权项 1. An intravenous pharmaceutical composition for treating a neuronal injury comprising a therapeutically effective amount of a biomembrane sealing agent comprising between 20 and 50% w/w of polyethylene glycol and at least one magnesium compound, wherein the polyethylene glycol comprises PEG 3350.
地址 Warsaw IN US